M/s,great Timec Pharma CO, Ltd, Pharmaceutical Import Profile — Nigeria (DGFT 2022–2026)

Name: M/s,great Timec Pharma CO, Ltd, Pharmaceutical Import Records from India — 3 Products, $570.9K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

M/s,great Timec Pharma CO, Ltd, — Pharmaceutical Importer Profile (2026) | 3 Products, $570.9K Trade | TransData Nexus

M/s,great Timec Pharma CO, Ltd,

Pharmaceutical Importer · Nigeria · Antifungals Focus · $570.9K Total Trade · DGFT Verified

M/s,great Timec Pharma CO, Ltd, is a pharmaceutical importer based in Nigeria with a total trade value of $570.9K across 3 products in 2 therapeutic categories. Based on 32 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. M/s,great Timec Pharma CO, Ltd, sources from 1 verified Indian supplier, with Bdh Industries Limited accounting for 100.0% of imports.

M/s,great Timec Pharma CO, Ltd, — Import Portfolio & Supplier Network

M/s,great Timec Pharma CO, Ltd, import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to M/s,great Timec Pharma CO, Ltd,?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Bdh Industries Limited	$570.9K	32	100.0%

M/s,great Timec Pharma CO, Ltd, sources from 1 verified Indian supplier across 4 distinct formulations. The sourcing is highly concentrated — Bdh Industries Limited accounts for 100.0% of total imports, indicating a strategic single-source relationship.

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Nystatin	Antifungals	$337.6K	24	0.6%	13
2	Proguanil	Antimalarial & Antiparasitic	$123.2K	4	0.0%	12
3	Praziquantel	Antimalarial & Antiparasitic	$110.2K	4	3.8%	4

M/s,great Timec Pharma CO, Ltd, imports 3 pharmaceutical products across 2 categories into Nigeria totaling $570.9K.

M/s,great Timec Pharma CO, Ltd, — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

M/s Great Timec Pharma Co. Ltd is a Nigerian pharmaceutical importer and distributor, established on September 28, 2004, with registration number RC-608081. The company is headquartered at Plot No. 19B, Niger Bridge Head, Housing Estate, Fegge, Onitsha, Anambra State, Nigeria. Great Timec Pharma Co. Ltd specializes in the importation and distribution of finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, sourced primarily from India. The company's product portfolio is concentrated in two therapeutic categories: antifungals and antimalarial & antiparasitic agents.

2Distribution Network

Great Timec Pharma Co. Ltd operates from its headquarters in Onitsha, Anambra State, Nigeria. While specific details about additional warehouse locations and logistics capabilities are not publicly available, the company's import activities suggest a distribution network that serves various regions within Nigeria. The focus on importing finished pharmaceutical formulations indicates a commitment to ensuring the availability of essential medications across the country.

3Industry Role

In Nigeria's pharmaceutical supply chain, Great Timec Pharma Co. Ltd functions as a primary wholesaler and distributor. By importing finished pharmaceutical formulations from India, the company plays a crucial role in supplying essential medications to local pharmacies, hospitals, and clinics. This position enables them to meet the demand for specific therapeutic agents, particularly in the antifungal and antimalarial & antiparasitic categories.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — M/s,great Timec Pharma CO, Ltd,

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

Great Timec Pharma Co. Ltd's sourcing strategy is highly concentrated, with all 32 shipments from India sourced exclusively from BDH Industries Limited, accounting for a total import value of $571,000. This single-source dependency may present risks, such as supply chain disruptions or pricing volatility. However, the consistent relationship over multiple shipments suggests a stable and reliable partnership. The company's portfolio concentration, with the top five products accounting for 100% of imports, further underscores the strategic importance of this supplier relationship.

2Supply Chain Resilience

The resilience of Great Timec Pharma Co. Ltd's supply chain is closely tied to its exclusive partnership with BDH Industries Limited. The lack of backup suppliers and limited formulation diversity may expose the company to risks in the event of supply chain disruptions. Additionally, the reliance on a single supplier for all imported products may limit the company's ability to adapt to changing market demands or regulatory requirements.

3Strategic Implications

Importing Pharmaceuticals into Nigeria — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Nigeria

1Regulatory Authority & Framework

In Nigeria, the National Agency for Food and Drug Administration and Control (NAFDAC) is the primary regulatory authority overseeing the importation, registration, and distribution of pharmaceutical products. Established under Decree No. 15 of 1993 and amended by Decree No. 19 of 1999, NAFDAC operates under the National Agency for Food and Drug Administration and Control Act Cap N1, Laws of the Federation of Nigeria (LFN), 2004. (freyrsolutions.com.ng) NAFDAC's mandate includes ensuring the safety, efficacy, and quality of drugs imported into Nigeria.

2Import Licensing & GMP

Importers of pharmaceutical products into Nigeria must obtain an import permit from NAFDAC, which involves submitting relevant documentation such as a Certificate of Pharmaceutical Product (CPP), a Free Sale Certificate, and product labeling information. Each drug must be registered with NAFDAC before importation, ensuring compliance with established standards for quality, efficacy, and safety. NAFDAC assigns a unique registration number to each approved drug, which must be displayed on the product packaging.

3Quality & Labeling

M/s,great Timec Pharma CO, Ltd, — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Great Timec Pharma Co. Ltd's focus on importing antifungal and antimalarial & antiparasitic agents aligns with the significant healthcare needs in Nigeria. The prevalence of fungal infections and malaria in the country drives the demand for effective treatments in these therapeutic areas. By concentrating on these categories, the company addresses critical health challenges and positions itself as a key supplier of essential medications.

2Sourcing Profile

The company's sourcing strategy is centered on importing generic drug formulations from India, particularly in the antifungal and antimalarial & antiparasitic categories. This approach allows Great Timec Pharma Co. Ltd to offer cost-effective treatments that meet the therapeutic needs of the Nigerian population. The reliance on a single supplier, BDH Industries Limited, suggests a strategic choice to maintain consistent product quality and supply reliability.

3Market Positioning

Based on its product mix, Great Timec Pharma Co. Ltd serves the wholesale distribution segment of the Nigerian pharmaceutical market. By importing and distributing essential medications, the company supplies local pharmacies, hospitals, and clinics, ensuring the availability of critical treatments for the Nigerian populace.

Seller's Guide — How to Become a Supplier to M/s,great Timec Pharma CO, Ltd,

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with Great Timec Pharma Co. Ltd, especially if they can offer products that complement the company's existing portfolio or provide alternative formulations in the antifungal and antimalarial & antiparasitic categories. Diversifying the supplier base could enhance the company's resilience and flexibility in meeting market demands.

2Requirements & Qualifications

Indian exporters seeking to supply Great Timec Pharma Co. Ltd must ensure that their products are registered with NAFDAC and comply with Nigerian regulatory standards. This includes obtaining the necessary import permits, adhering to Good Manufacturing Practice (GMP) standards recognized by NAFDAC, and ensuring that product labeling meets NAFDAC's requirements.

3How to Approach

To establish a relationship with Great Timec Pharma Co. Ltd, Indian exporters should initiate contact through formal channels, providing detailed product information, including NAFDAC registration numbers and GMP certifications. Participating in relevant tenders and trade fairs can also facilitate introductions. Understanding NAFDAC's regulatory filing procedures and timelines is crucial for timely product registration and importation. Building a strong partnership will require consistent communication, adherence to regulatory requirements, and a commitment to quality and reliability.

Frequently Asked Questions — M/s,great Timec Pharma CO, Ltd,

What products does M/s,great Timec Pharma CO, Ltd, import from India?

M/s,great Timec Pharma CO, Ltd, imports 3 pharmaceutical products across 2 categories. Top imports: Nystatin ($337.6K), Proguanil ($123.2K), Praziquantel ($110.2K).

Who supplies pharmaceuticals to M/s,great Timec Pharma CO, Ltd, from India?

M/s,great Timec Pharma CO, Ltd, sources from 1 verified Indian suppliers. The primary supplier is Bdh Industries Limited (100.0% of imports, $570.9K).

What is M/s,great Timec Pharma CO, Ltd,'s total pharmaceutical import value?

M/s,great Timec Pharma CO, Ltd,'s total pharmaceutical import value from India is $570.9K, based on 32 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does M/s,great Timec Pharma CO, Ltd, focus on?

M/s,great Timec Pharma CO, Ltd, imports across 2 categories. The largest: Antifungals (59.1%), Antimalarial & Antiparasitic (40.9%).

Get Full M/s,great Timec Pharma CO, Ltd, Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.

Formulation	Value	Ships
Timec nystatin oral tablets BP 500000 IU	$187.7K	12
Timec nystatin vaginal	$149.9K	12
Proguanil tablets BP 100 MG.-nafdac no.	$123.2K	4
Praziquantel tablets USP 600 MG.	$110.2K	4